Telix Submits NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, May 28, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has submi...

Related Keywords

Melbourne ,Victoria ,Australia ,Hinata ,Kanagawa ,Japan ,United States ,Switzerland ,Belgium ,Canada ,Australian ,Americans ,America ,Kyahn Williamson ,Christian Behrenbruch ,Mike Crosby ,Worldj Mens Health ,Ge Healthcare ,Corporate Communications ,Telix Pharmaceuticals Limited ,Telix Pharmaceuticals ,Health Canada ,Telix Pharmaceuticals Limited Disclosure Committee ,Linkedin ,Drug Administration ,Australian Securities Exchange ,Australian Therapeutic Goods Administration ,Pharmaceuticals Limited ,New Drug Application ,Prostate Cancer Awareness ,Managing Director ,Epidemiol Biomarkers ,Practice Guidelines ,Cancer Sites ,Cancer Stat ,Accessed May ,